Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 6.7% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 3,830,302 shares of the real estate investment trust’s stock after acquiring an additional 240,006 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.42% of Omega Healthcare Investors worth $155,893,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Allworth Financial LP boosted its holdings in shares of Omega Healthcare Investors by 12.0% in the 3rd quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock valued at $93,000 after acquiring an additional 244 shares during the last quarter. Venturi Wealth Management LLC grew its position in Omega Healthcare Investors by 29.4% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 286 shares during the period. Cutter & CO Brokerage Inc. raised its stake in shares of Omega Healthcare Investors by 3.7% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock valued at $281,000 after buying an additional 290 shares during the last quarter. NCP Inc. lifted its holdings in shares of Omega Healthcare Investors by 10.3% in the 2nd quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock valued at $113,000 after buying an additional 310 shares during the period. Finally, V Square Quantitative Management LLC lifted its holdings in shares of Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 323 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on OHI shares. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. BMO Capital Markets lifted their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada upped their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research note on Monday, November 11th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $40.00.

Omega Healthcare Investors Stock Performance

NYSE OHI opened at $40.11 on Monday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock’s fifty day moving average is $40.62 and its two-hundred day moving average is $37.05. The firm has a market capitalization of $10.83 billion, a P/E ratio of 29.49, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insiders Place Their Bets

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.